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при кількості спостережень – 29) AR=0,21; ризик 
дисліпідемії при АГ першого ступеня (кількість 
спостережень – 5 при кількості випадків – 2) 
AR=0,4, RR=1,9 (достовірно каппа 95%) та етіо-
логічної частки (EF, %) АГ у 47,4%; При АГ дру-
гого ступеня (кількість спостережень – 88 при 
кількості випадків – 75) AR=0,85, RR=4,0 (до-
стовірно каппа 95%) та EF=75%. Тобто най-
більший ризик дисліпідемії у хворих на АГ дру-
гого ступеня. 
При підрахунку ІА залежно від наявності 
ХОЗЛ (кількість спостережень – 125 при кіль-
кості випадків – 60) атрибутивний ризик (AR) 
становив 0,48. При наявності АГ за відсутності 
ХОЗЛ (кількість спостережень – 30, кількість 
випадків – 23) AR=0,77. Залежно від стадії ХОЗЛ 
виявлено, що при ХОЗЛ першої стадії (кількість 
спостережень – 43 при кількості випадків – 21) 
AR=0,48, (достовірно каппа 95%); При ХОЗЛ 
другої стадії (кількість спостережень – 49 при 
кількості випадків – 39) AR=0,79, RR=1,03 та 
EF=3% (достовірно каппа 95%). Тобто найбіль-
ший ризик дисліпідемії у хворих на ХОЗЛ другої 
стадії.  
ПІДСУМОК 
Найбільший ризик дисліпідемії у працівників 
підземного видобування залізної руди, що мають 
АГ другого ступеня та ХОЗЛ другої стадії. Ви-
значення ризику дисліпідемії дає підставу для 
подальшої розробки методів своєчасної діагно-
стики та впровадження комплексу заходів, спря-
мованих на запобігання розвитку дисліпідемії як 
основного з факторів розвитку атеросклерозу та 
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Atrial fibrillation (AF) is one of the most com-
mon forms of arrhythmias, which leads to acute 
stroke and has a negative social significance. Every 
fifth case of stroke is due to the presence of atrial 
fibrillation. It is known, that spread of comorbidity 
is associated with age. According to literature, the 
prevalence of atrial fibrillation is also increasing 
with age: almost 10% of people over the age of 80 
suffer from AF. The study of risk factors and co-
morbidity in patients with atrial fibrillation of non-
valvular genesis requires a detailed analysis. 
The aim of the study was to evaluate the risk 
factors and the incidence of comorbidity in patients 
with coronary heart disease depending on the pre-
sence of atrial fibrillation. 
MATERIALS AND METHODS 
A retrospective analysis of 222 case histories of 
illnesses of patients with coronary heart disease who 
undergo inpatient treatment, aged from 39 to 
88 years, has been conducted. Depending on the pre-
sence of atrial fibrillation, all patients were divided 
into 2 groups: group 1 (main) – patients with coro-
nary heart disease with atrial fibrillation (n=105), 
group 2 (comparison) – patients with coronary heart 
disease without atrial fibrillation (n=117).  
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RESULTS AND DISCUSSION  
In the group of patients without AF, the pro-
portion of patients with inherited exacerbations of 
coronary heart disease was 64.29%, while in the 
main group – 25.0%, the differences did not reach 
the statistically significant level, but this relationship 
is confirmed by the results of the rank correlation 
analysis – between the presence AP and heredity 
there was revealed a significant weak feedback – 
c= –0.21 (p<0.05). The diseases that were observed 
in the examined patients with coronary artery 
disease present acute violation of cerebral circu-
lation, angina pectoris, acute myocardial infarction, 
hypertension, diabetes, pathology of the kidneys and 
the thyroid gland, diastolic dysfunction and obesity. 
The groups differed in the proportion of patients 
with stroke – in the group with AF, It was 
significantly (p=0.002) higher – 23.81%, as com-
pared to 8.55% in the comparison group. 
CONCLUSIONS 
The presence of atrial fibrillation in patients with 
coronary heart disease is associated with a high 
degree of comorbidity. First of all, with the com-
bination of coronary heart disease and atrial 
fibrillation, a high incidence of hypertension, dia-
betes mellitus, obesity, acute stroke, kidney disease 
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Cardiovascular disease (CVD) is a major cause 
of mortality in rheumatoid arthritis (RA). In the 
literature are conflicting data on the use of statins in 
patients with RA, indicating a lack of attention to the 
issue of prevention of CVD in this category of 
patients. 
The aim of the study was to improve the ef-
ficiency of the treatment of rheumatoid arthritis by 
including basic treatment rosuvastatin. 
MATERIALS AND METHODS 
The study included 43 patients with RA. A sur-
vey conducted by the protocol patients (DAS28 
index, visual analog scale (VAS), morning stiffness). 
The study of lipid metabolism include: determining 
the level of total cholesterol (total cholesterol), HDL 
cholesterol (HSLPVSCH) and low density 
(HSLPNSCH), atherogenic index (AI), triglycerides 
(TG). Total cardiovascular risk assessment was per-
formed using a table SCORE. Surveyed patients 
divided into groups: primary (n=20) (basic therapy 
and rosuvastatin, 10 mg 1 time per day) and com-
parison (n=23) (basic therapy that included metho-
trexate, nonsteroidal anti-inflammatory drugs, gluco-
corticoids in medium therapeutic doses). 
RESULTS AND DISCUSSION  
As a result of the treatment found that patients 
with a primary and group comparison, there was a 
positive dynamics of clinical indicators of inflam-
matory activity (DAS28, VAS, morning stiffness). 
In the study group experienced a significant decrease 
(p<0.05) at the same time as in the comparison 
group had a tendency to decrease. Noted a reduction 
parameters: CRP (Δ137% main group and the com-
parison group Δ221%), ESR (Δ139% and Δ226% 
respectively). Also noted the changes in the lipid 
profile. Significantly decreased in the study group 
performance total cholesterol (Δ131% versus 
